Posted 30 maj 2017 in Okategoriserade
On May 11 ISAB CSO and founder Per Gerde, and Product and Sales Manager Mikael Mikko, travelled to Hanover, Germany to install a new PreciseInhale system for Fraunhofer’s…
Read morePosted 08 maj 2017 in Okategoriserade
Inhalation Sciences and AstraZeneca have entered into a collaboration to use PreciseInhale for the evaluation of inhaled drugs. PreciseInhale is recognized as exceptionally innovative by several pioneering groups…
Read morePosted 08 maj 2017 in Okategoriserade
Inhalation Sciences and AstraZeneca have entered into a collaboration to use PreciseInhale for the evaluation of inhaled drugs. PreciseInhale is recognized as exceptionally innovative by several pioneering groups…
Read morePosted 07 april 2017 in Okategoriserade
A new paper from ISAB and Astra Zeneca shows how DissolvIt simulates the dissolution and absorption of dry powder aerosols in the lung. The paper describes successful in…
Read morePosted 07 april 2017 in Okategoriserade
A new paper from ISAB and Astra Zeneca shows how DissolvIt simulates the dissolution and absorption of dry powder aerosols in the lung. The paper describes successful in…
Read morePosted 23 mars 2017 in Okategoriserade
Inhalations Sciences AB (ISAB) has signed a purchase order for its dry powder aerosol system PreciseInhale, with one of Europe’s leading inhalation Research Groups. Fredrik Sjövall, ISAB CEO:…
Read morePosted 23 mars 2017 in Okategoriserade
Inhalations Sciences AB (ISAB) has signed a purchase order for its dry powder aerosol system PreciseInhale, with one of Europe’s leading inhalation Research Groups. Fredrik Sjövall, ISAB CEO:…
Read morePosted 08 mars 2017 in Okategoriserade
ISAB is delivering two presentations detailing its nanoparticle research at this year’s SOT: A poster shows how copper and copper oxide nanoparticles dissolve in the lung, co-authored by…
Read morePosted 08 mars 2017 in Okategoriserade
ISAB’s R&D dry powder aerosol system PreciseInhale has been purchased by Dow Chemicals, Chiesi, King’s College London, and produced six patents, with more in the pipeline. For 17…
Read morePosted 17 februari 2017 in Okategoriserade
On February 13 2017 Karolinska Development AB (KDEV) announced it was divesting its shares in ISAB to a new consortium made up of Råsunda Förvaltning AB, Inhalation Sciences`…
Read more